Wound Biologics Market by Product, Wound Type, End-User - Russia Ukraine Conflict and High Inflation

Description

List of Tables

The Global Wound Biologics Market is forecasted to grow significantly, with a projected USD 4,980.96 million in 2023 at a CAGR of 9.82% and expected to reach a staggering USD 9,704.12 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Wound Biologics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Wound Biologics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Biologic Skin Substitutes and Topical Agents. The Biologic Skin Substitutes is further studied across Acellular Animal-derived Products, Biosynthetic Products, and Human Donor Tissue-derived Products. The Biologic Skin Substitutes commanded largest market share of 43.53% in 2022, followed by Topical Agents.

Based on Wound Type, market is studied across Burns, Surgical and Traumatic Wounds, and Ulcers. The Ulcers is further studied across Diabetic Foot Ulcers, Pressure Ulcers, and Venous Ulcers. The Surgical and Traumatic Wounds commanded largest market share of 42.71% in 2022, followed by Ulcers.

Based on End-User, market is studied across Ambulatory Surgery Centers, Burn Centers, Hospitals, and Wound Clinics. The Hospitals commanded largest market share of 39.22% in 2022, followed by Ambulatory Surgery Centers.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 42.03% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Wound Biologics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Wound Biologics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Wound Biologics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Wound Biologics Market?

4. What is the competitive strategic window for opportunities in the Global Wound Biologics Market?

5. What are the technology trends and regulatory frameworks in the Global Wound Biologics Market?

6. What is the market share of the leading vendors in the Global Wound Biologics Market?

7. What modes and strategic moves are considered suitable for entering the Global Wound Biologics Market?

Product Code: MRR-0315DDADCE4C

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Wound Biologics Market, by Product, 2022 vs 2030
4.3. Wound Biologics Market, by Wound Type, 2022 vs 2030
4.4. Wound Biologics Market, by End-User, 2022 vs 2030
4.5. Wound Biologics Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Government Initiatives Regarding Wound Care Treatment
  - 5.1.1.2. Rising Incidences of Burn Injuries and Road Accidents
  - 5.1.1.3. Increasing Geriatric Population Globally
- 5.1.2. Restraints
  - 5.1.2.1. High Cost of Wound Treatment
- 5.1.3. Opportunities
  - 5.1.3.1. Introduction of Innovative Wound Care Biologics
  - 5.1.3.2. Potential Need for Bioengineered Skin Substitutes in Surgeries
- 5.1.4. Challenges
  - 5.1.4.1. Lack of Trained Physicians and Complications Associated with the Contamination
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Wound Biologics Market, by Product

6.1. Introduction
6.2. Biologic Skin Substitutes
- 6.2.1. Acellular Animal-derived Products
- 6.2.2. Biosynthetic Products
- 6.2.3. Human Donor Tissue-derived Products
6.3. Topical Agents

7. Wound Biologics Market, by Wound Type

7.1. Introduction
7.2. Burns
7.3. Surgical and Traumatic Wounds
7.4. Ulcers
- 7.4.1. Diabetic Foot Ulcers
- 7.4.2. Pressure Ulcers
- 7.4.3. Venous Ulcers

8. Wound Biologics Market, by End-User

8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Burn Centers
8.4. Hospitals
8.5. Wound Clinics

9. Americas Wound Biologics Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Wound Biologics Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Wound Biologics Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

1. 3M Company

2. Anika Therapeutics, Inc

3. Avita Medical, Inc.

4. Bioventus Inc.

5. Blaine Labs Inc.

6. ConvaTec Group PLC

7. Cytori Therapeutics Inc.

8. Integra Lifesciences Holdings Corporation

9. Kerecis hf

10. Marine Polymer Technologies, Inc.

11. MediWound Ltd.

12. MIMEDX GROUP, INC.

13. Molnlycke Health Care AB

14. Nuo Therapeutics, Inc.

15. Organogenesis Inc.

16. Polymedics Innovations GmbH

17. Royal Biologics, Inc.

18. Skye Biologics Holdings, LLC

19. Smith & Nephew PLC

20. Stability Biologics

21. Stryker Corporation

22. Surgilogix, LLC

23. Tides Medical

24. Vericel Corporation

25. Viatris Inc.